Carlisle Companies Incorporated (CSL)

Pretax margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Earnings before tax but after interest (EBT) US$ in thousands 978,900 1,194,400 517,200 398,600 590,100
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Pretax margin 21.34% 21.92% 10.75% 10.04% 13.16%

December 31, 2023 calculation

Pretax margin = EBT ÷ Revenue
= $978,900K ÷ $4,586,900K
= 21.34%

The pretax margin of Carlisle Companies Inc. has shown a generally positive trend over the last five years. The company's pretax margin increased from 12.37% in 2019 to 20.28% in 2023, indicating improved profitability before accounting for taxes. This upward trend suggests that Carlisle Companies Inc. has been effectively managing its operating expenses and generating higher profits relative to its total revenue. The consistent improvement in pretax margin reflects the company's ability to efficiently control costs and maximize its operational efficiency. Overall, the increasing pretax margin is a positive indicator of Carlisle Companies Inc.'s financial performance and stability over the analyzed period.


Peer comparison

Dec 31, 2023

Company name
Symbol
Pretax margin
Carlisle Companies Incorporated
CSL
21.34%
West Pharmaceutical Services Inc
WST
24.52%